Alpha-Methyl-l-Tryptophan Positron Emission Tomography in Epilepsy With Cortical Developmental Malformations

Pediatric Neurology

Volumn 39, Issue 3, 2008, Pages 181-188

  Wakamoto, Hiroyuki ^a   Chugani, Diane C ^a   Juhász, Csaba ^a   Muzik, Otto ^a   Kupsky, William J ^a   Chugani, Harry T ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA METHYLTRYPTOPHAN C 11; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN MALFORMATION; BRAIN REGION; CHILD; DIAGNOSTIC ACCURACY; DRUG UPTAKE; ELECTROENCEPHALOGRAM; EPILEPTIC FOCUS; FEMALE; HUMAN; HUMAN TISSUE; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; BRAIN; CARBON RADIOISOTOPES; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; EPILEPSY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; TRYPTOPHAN;

EID: 49749094756     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2008.05.014     Document Type: Article

References (34)

1. Diksic M., Nagahiro S., Chaly T., Sourkes T.L., Yamamoto Y.L., and Feindel W. Serotonin synthesis rate measured in living dog brain by positron emission tomography. J Neurochem 56 (1991) 153-162
2. Chugani D.C., Muzik O., Behen M., et al. Developmental changes in brain serotonin synthesis in autistic and nonautistic children. Ann Neurol 45 (1999) 287-295
3. 11C]-methy-l-tryptophan PET. Ann Neurol 44 (1998) 858-866
4. Fedi M., Reutens D.C., Okazawa H., et al. Localizing value of alpha-methy-l-tryphophan PET in intractable epilepsy of neocortical origin. Neurology 57 (2001) 1629-1636
5. Juhász C., Chugani D.C., Muzik O., et al. Alpha-methyl-l-tryphophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 60 (2003) 960-968
6. 11C]methyl-l-tryptophan positron emission tomography for reoperation after failed epilepsy surgery. Epilepsia 45 (2004) 124-130
7. Asano E., Chugani D.C., Muzik O., et al. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 54 (2000) 1976-1984
8. Sisodiya S.M. Surgery for malformations of cortical development causing epilepsy. Brain 123 (2000) 1075-1091
9. Wyllie E., Comair Y.G., Kotagal P., Bulacio J., Bingman W., and Ruggeri P. Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 44 (1998) 740-748
10. Bingaman W.E., and Cataltepe O. Epilepsy surgery for focal malformation of cortical development. In: Luders H.O., and Comair Y.G. (Eds). Epilepsy surgery. 2nd ed (2001), Lippincott Williams & Wilkins, Philadelphia, Pa 781-791
11. 11C] methyl-l-tryptophan. Nucl Med Biol 23 (1996) 1005-1008
12. Muzik O., Chugani D.C., Shen C., et al. An objective method for localization of cortical asymmetries using positron emission tomography to aid in surgical resection of epileptic foci. Comput Aid Surg 3 (1998) 74-82
13. Pietrzyk U., Herholz K., and Heiss W.D. Three dimensional alignment of functional and morphological tomograms. J Comput Assist Tomogr 14 (1990) 51-59
14. Pietrzyk U., Herholz K., Fink G., et al. An interactive technique for three-dimensional image registration: Validation for PET, SPECT, MRI, and CT brain studies. J Nucl Med 35 (1994) 2011-2018
15. Barkovic A.J., Kuzniecky R.I., Jackson G.D., Guerrini R., and Dobyns W.B. A developmental and genetic classification for malformations of cortical development. Neurology 65 (2005) 1873-1887
16. Chugani D.C. Serotonin in autism and pediatric epilepsies. Ment Retard Dev Disabil Res Rev 10 (2004) 112-116
17. Chugani H.T., and Chugani D.C. Imaging of serotonin mechanisms in epilepsy. Epilepsy Curr 5 (2005) 201-206
18. 11C]methyl-l-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology 60 (2003) 756-761
19. Trottier S., Evrard B., Vignal J.P., Scarabin J.M., and Chauvel P. The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia. Epilepsy Res 25 (1996) 79-106
20. Louw D., Sutherland G.B., Glavin G.B., and Girvin J. A study of monoamine metabolism in human epilepsy. Can J Neurol Sci 16 (1989) 394-397
21. Pintor M., Mefford I.N., Hutter I., Pocotte S.L., Wyler A.R., and Nadi N.S. Levels of biogenic amines, their metabolites and tyrosine hydroxylase in the human epileptic temporal cortex. Synapse 5 (1990) 152-156
22. Juhász C., Chugani D.C., and Chugani H.T. Pathophysiology and functional consequences of human partial epilepsy: Lessons from positron emission tomography studies. Acta Physiol Hung 90 (2003) 281-303
23. Salgado D., and Alkadhi K.A. Inhibition of epileptiform activity by serotonin in rat CA1 neurons. Brain Res 669 (1995) 176-182
24. Perkins M.N., and Stone T.W. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with endogenous excitant quinolinic acid. Brain Res 247 (1982) 184-187
25. Perkins M.N., and Stone T.W. Pharmacology and regional variation of quinolinic acid-evoked excitations in rat central nervous system. J Pharmacol Exp Ther 226 (1983) 551-557
26. Vezzani A., Ungerstedt U., French E.D., and Schwartz R. In vivo brain dialysis of amino acids and simultaneous EEG measurements following intrahippocampal quinolinic acid injections: Evidence for a dissociation between neurochemical changes and seizures. J Neurochem 45 (1985) 335-344
27. Lapin I.P. Stimulant and convulsant effects of kynurenines injected into brain ventricles in mice. J Neural Transm 32 (1978) 37-43
28. Lapin I.P. Effect of kynurenine and quinolinic acid on the actions of convulsants in mice. Pharmacol Boichem Behav 13 (1980) 17-20
29. Lapin I.P. Convulsant action of intracerebroventricularly administered L-kynurenine sulphate, quinolinic acid and of derivatives of succinic acid, and effects of amino acids, structure-activity relationships. Neuropharmacology 21 (1982) 1227-1233
30. Heyes M.P., Wyler A.R., Devinsky O., Yergey J.A., Markey S.P., and Nadi N.S. Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizures. Epilepsia 31 (1990) 172-177
31. Saito K., Nowak Jr. T.S., Suyama K., et al. Kynurenine pathway enzyme in brain: Responses to ischemic brain injury versus systemic immune activation. J Neurochem 61 (1993) 2061-2070
32. Chugani D.C., Heyes M.P., Kuhn D.M., and Chugani H.T. Evidence that α[C-11]methyl-l-tryptophan PET traces tryptophan metabolism via the kynurenine pathway in tuberous sclerosis complex. Soc Neurosci Abstr 24 (1998) 1757
33. Sisodiya S.M., Martinian L., Scheffert G.L., et al. Vascular colocalization of P-glycoprotein, multidrug-resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies. Neuropathol Appl Neurobiol 32 (2006) 51-63
34. Mackenzie S.M., Howells A.J., Cox G.B., and Ewart G.D. Sub-cellular localization of the white/scarlet ABC transporter to pigment granule membranes within the compound eye of Drosophilia melanogaster. Genetica 108 (2000) 239-252